Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kanami Shimokuri
EBV-associated Gastric Cancer Evades T-Cell Immunity by PD-1/PD-L1 Interactions
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Related publications
Enhancement of T Cell Immunity to Osteosarcoma Through Modulation of PD-1/PD-L1 Interactions
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse With Cancer After Allogeneic Stem Cell Transplantation
Cancer Research
Cancer Research
Oncology
Suppression of IL-22–Producing T Helper 22 Cells by RPE Cells via PD-L1/PD-1 Interactions
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4 + T Cell Immunity
Immunity
Infectious Diseases
Allergy
Immunology
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Expression of PD‑1, PD‑L1 and PD‑L2 Is Associated With Differentiation Status and Histological Type of Endometrial Cancer
Oncology Letters
Cancer Research
Oncology
Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-1 Receptor (PDCD1; PD-1; CD279); Programmed Cell Death 1 Ligand 1 (CD274 Molecule; PD-L1; B7-H1)
Science-Business eXchange
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
